Carroucell

Carroucell

Recherche en biotechnologie

Grenoble, Auvergne-Rhone-Alpes 904 abonnés

Whatever the adherent cell, whatever the culture environment, we have the microcarrier solution, in R&D and GMP grade!

À propos

Tarek Fathallah, a Grenoble-based scientist and inventor, has uncovered a breakthrough in sol-gel technology with profound implications for the Healthcare industry. Driven by a passion for impactful innovation, he harnessed these properties to create tailored solutions for Cell and Gene Therapy Applications. Rooted in extensive biomanufacturing expertise, this concept addresses industry challenges by integrating cutting-edge technology into adherent cell manufacturing. Through groundbreaking research, a Microcarrier was developed, surpassing previous limitations and establishing Carroucell as a leading authority, protected by patents. In 2022, Carroucell advanced adherent cell production's supply chain with efficient scaffolds like Flexi Grow™ microcarriers, significantly increasing culture yield while preserving cell quality. As the visionary behind the new Microcarrier generation, Carroucell ensures heightened productivity through a distinctive warranty and a Charter commitment statement. Carroucell prioritizes Good Manufacturing Practices (GMP) for comprehensive clinical trial support, adhering strictly to GMP guidelines, elevating product reliability and integrity for researchers and clinicians in trials.

Site web
www.carroucell.com
Secteur
Recherche en biotechnologie
Taille de l’entreprise
11-50 employés
Siège social
Grenoble, Auvergne-Rhone-Alpes
Type
Société civile/Société commerciale/Autres types de sociétés
Fondée en
2016
Domaines
cell culture, stem cell, cell therapy, Static environments, Cell flasks, MSC, IPSC, Keratinocytes, Chondrocytes, GMP, R&D et scale-up

Lieux

Employés chez Carroucell

Nouvelles

Pages similaires

Parcourir les offres d’emploi

Financement

Carroucell 1 round en tout

Dernier round

Série A

1 499 697,00 $US

Voir plus d’informations sur Crunchbase